| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/23/2006 | US20060062843 Extended release formulation |
| 03/23/2006 | US20060062842 Method of administering a compound to multi-drug resistant cells |
| 03/23/2006 | US20060062841 Liposomal vectors |
| 03/23/2006 | US20060062840 Lipid microtubules with contolled bilayer numbers |
| 03/23/2006 | US20060062839 Efficient liposomal encapsulation under mild conditions |
| 03/23/2006 | US20060062838 Biosynchronous transdermal drug delivery |
| 03/23/2006 | US20060062837 Dual activating TDD |
| 03/23/2006 | US20060062836 Methods of device-assisted drug delivery |
| 03/23/2006 | US20060062832 Sanitizing wipes with microbicidal properties cross-reference to related applications |
| 03/23/2006 | US20060062831 formed of a polymeric material associated with a glass which comprises an antimicrobial element, preferably silver; suitable for prolonged direct contact with a wound |
| 03/23/2006 | US20060062830 Process for producing edible orally administered agent of laminate film form and compression bonding apparatus |
| 03/23/2006 | US20060062829 Medical pad, and method for making and using |
| 03/23/2006 | US20060062827 Nutritional supplement composition and method |
| 03/23/2006 | US20060062826 Process for the production of sustained release drug delivery devices |
| 03/23/2006 | US20060062816 Improved absorption of mentrual fluid and decreased amounts on skin and hair; liquid pervious topsheet; the lotion contains a petroleum based hydrocarbon, lower molecular weight glycols or polyols and a fatty alcohol |
| 03/23/2006 | US20060062815 Therapeutic glove |
| 03/23/2006 | US20060062814 Oral compositions which mask the salty taste of salts |
| 03/23/2006 | US20060062812 Novel compositions |
| 03/23/2006 | US20060062811 Medicinal cooling emulsions |
| 03/23/2006 | US20060062810 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 03/23/2006 | US20060062809 Solid dispersions comprising two different polymer matrixes |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062768 Biocompatible hydrogel compositions |
| 03/23/2006 | US20060062742 Compositions for reduction of human malodor |
| 03/23/2006 | US20060062741 Elicits an immunological response and can even inhibit colonization by NTHi or M. catarrhalis and prevent otitis media and other respiratory diseases caused by NTHi or M. catarrhalis infection; drug delivery |
| 03/23/2006 | US20060062740 provide a capsule for holding a powder which facilitates its filling with the powder; enabling an airflow to be created through the body from the second opening to the first opening which is able to entrain powder in the exterior environment into the internal chamber for filling; Dry powder inhalant |
| 03/23/2006 | US20060062735 Combination therapy and means for carrying out said therapy |
| 03/23/2006 | US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies |
| 03/23/2006 | DE19826517B4 Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette Process for the preparation of film-coated tablets with cyclophosphamide as active ingredient and cyclophosphamide film-coated tablet prepared therefrom |
| 03/23/2006 | DE102004046026A1 Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide A process for preparing dry powders of one or more carotenoids |
| 03/23/2006 | DE102004036437A1 Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform Multiparticulate dosage form for sparingly soluble active ingredients, and a process for preparing the drug form |
| 03/23/2006 | DE102004012973B4 Kapsel zur Aufnahme wenigstens einer pharmazeutischen Zubereitung, insbesondere für Pulverinhalatoren, sowie Kapselkette bestehend aus mehreren solcher Kapseln Capsule for receiving at least a pharmaceutical preparation, especially for powder inhalers, as well as capsule chain consisting of a plurality of such capsules |
| 03/23/2006 | CA2588245A1 Quick dissolve medicament and method of manufacturing |
| 03/23/2006 | CA2584714A1 Covered stent with controlled therapeutic agent diffusion |
| 03/23/2006 | CA2582005A1 Delivering iron to an animal |
| 03/23/2006 | CA2581076A1 D-methionine formulation with improved biopharmaceutical properties |
| 03/23/2006 | CA2580770A1 Substance delivery device |
| 03/23/2006 | CA2580659A1 Corticosteroid having low systemic absorption |
| 03/23/2006 | CA2580439A1 Lubricious compounds for biomedical applications using hydrophilic polymers |
| 03/23/2006 | CA2580330A1 A controlled slow release formulation of thiamine and use thereof in the treatment of pathologies connected to defective process of learning and memorization |
| 03/23/2006 | CA2580286A1 Dermally applicable formulations for treating skin diseases in animals |
| 03/23/2006 | CA2580202A1 Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
| 03/23/2006 | CA2579957A1 Delivery vehicle containing nanoparticles |
| 03/23/2006 | CA2579725A1 Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor |
| 03/23/2006 | CA2579177A1 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 03/23/2006 | CA2578845A1 Multi-layer tablets and bioadhesive dosage forms |
| 03/23/2006 | CA2578534A1 Transdermal therapeutic system comprising an adhesive layer, method of siliconizing the back layer of the system and use of said back layer |
| 03/23/2006 | CA2578248A1 Multiple sclerosis treatment |
| 03/23/2006 | CA2570450A1 Pharmaceutically elegant, topical anhydrous aerosol foam |
| 03/23/2006 | CA2544776A1 Polyethylene oxide-based films and drug delivery systems made therefrom |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1637185A1 Controlled-release formulations containing tryptophan and/or its metabolites |
| 03/22/2006 | EP1637173A2 Particle delivery |
| 03/22/2006 | EP1637170A1 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 03/22/2006 | EP1637165A1 Medicinal cooling emulsions |
| 03/22/2006 | EP1637164A2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/22/2006 | EP1637157A1 Pharmaceutical composition for the treatment of pelvic pain |
| 03/22/2006 | EP1637154A2 High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 03/22/2006 | EP1637149A1 Dietary supplement composition for the man |
| 03/22/2006 | EP1637145A1 Material promoting wound healing |
| 03/22/2006 | EP1637144A1 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 03/22/2006 | EP1637142A2 Stable solid formulation of enalapril salt and process for preparation thereof |
| 03/22/2006 | EP1637131A1 Cataplasm base and cataplasm using the same |
| 03/22/2006 | EP1637130A1 Microcapsules for the administration of active ingredients |
| 03/22/2006 | EP1637129A1 Composition comprising alfuzosin |
| 03/22/2006 | EP1637128A2 Use of simple amino acids to form porous particles |
| 03/22/2006 | EP1637127A2 Generation of therapeutic microfoam |
| 03/22/2006 | EP1637126A2 Methods for treating inflammation of the eye |
| 03/22/2006 | EP1636345A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 03/22/2006 | EP1636295A2 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device |
| 03/22/2006 | EP1636262A1 Interferon gamma-like protein |
| 03/22/2006 | EP1636260A2 Improved secretion of neublastin |
| 03/22/2006 | EP1635894A2 Medication infusion device using negatively biased ambient pressure medication chamber |
| 03/22/2006 | EP1635875A2 In-situ gelling drug delivery system |
| 03/22/2006 | EP1635874A1 Compositions for oral administration of campothecin and its analogs |
| 03/22/2006 | EP1635854A2 Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| 03/22/2006 | EP1635853A2 Topical composition for the treatment of skin disorders and methods of using the same |
| 03/22/2006 | EP1635852A1 Nail restructuring compositions for topical application |
| 03/22/2006 | EP1635842A1 Treatment of amd with combination of ingredients |
| 03/22/2006 | EP1635830A2 Granulate formulation of the rapamycin ester cci-779 |
| 03/22/2006 | EP1635814A1 Stable compositions of atorvastatin prepared with wet granulation |
| 03/22/2006 | EP1635802A1 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
| 03/22/2006 | EP1635799A2 Pharmaceutical formulations of amyloid inhibiting compounds |
| 03/22/2006 | EP1635797A1 Hydrophilic adhesive compositions for delivery of herbal medicines |
| 03/22/2006 | EP1635796A1 Fast dissolving orally consumable films containing sucralose as a sweetener |
| 03/22/2006 | EP1635795A1 Controlled release pharmaceutical compositions of tolterodine and processes for their preparation |
| 03/22/2006 | EP1635794A2 Nitrofurantoin controlled release dosage form |
| 03/22/2006 | EP1635793A1 A composition for an enteric coating of natural product containing lectin |
| 03/22/2006 | EP1635792A1 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 03/22/2006 | EP1635791A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 03/22/2006 | EP1635790A1 Pharmaceutical compositions based on diclofenac derivate |
| 03/22/2006 | EP1635789A1 Process for forming amorphous atorvastatin |
| 03/22/2006 | EP1635788A1 Pharmaceutical compositions of atorvastatin |
| 03/22/2006 | EP1635787A2 Bioerodible sustained release drug delivery systems |
| 03/22/2006 | EP1635786A2 Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agent microparticle with a partial or complete amino acid and/or phospholipid coat |
| 03/22/2006 | EP1635784A2 Improved metered dose inhaler |
| 03/22/2006 | EP1635783A2 Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 03/22/2006 | EP1635770A2 Antifungal nail coat and method of use |
| 03/22/2006 | EP1635764A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 03/22/2006 | EP1635762A2 Low dose pharmaceutical powders for inhalation |